Sample Post

Sample Post test

Sample Image

 

14%
portion of total synergy savings derived from IT consolidation
  • Industries
  • Practice Areas
View all
  • Related Insight
Counterfeit Ozempic: The EU’s EMVS Steps Up
The European Medicines Verification System (EMVS) has been a game-changer in enhancing the safety and

Explore Other Successful Projects

See all client results
Counterfeit Ozempic: The EU’s EMVS Steps Up
The European Medicines Verification System (EMVS) has been a game-changer in enhancing the safety and integrity of the pharmaceutical supply chain across Europe. By implementing a unique identifier (UI) for each medicinal product, EMVS facilitates the real-time verification of product authenticity
IDMP: The Latest in Identification of Medicinal Products
As the pharmaceutical landscape continues to evolve, the need for standardized identification and management of medicinal products has never been more critical. The Identification of Medicinal Products (IDMP) standards, established by the International Organization for Standardization (ISO) and supported by regulatory bodies like the European Medicines Agency (EMA), are crucial for ensuring global consistency, safety, and efficiency in drug development and regulation. As of 2024, these standards are more relevant than ever for life sciences professionals.
Navigating the Evolving Landscape of EMVS: Challenges and Opportunities for Pharmaceutical Industry Stakeholders
The European Medicines Verification System (EMVS) has been a game-changer in enhancing the safety and integrity of the pharmaceutical supply chain across Europe. By implementing a unique identifier (UI) for each medicinal product, EMVS facilitates the real-time verification of product authenticity